Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > One reason for FDA deprioritization

<< Previous

Bullboard Posts

Next >>

Comment by Allforoilandgason Nov 02, 2020 5:29am

248 Views

Post# 31821554

RE:RE:One reason for FDA deprioritization

The only reason for US deprioritization is that they are the ones selling their tests to Canada. So why would they aprove testers made in Canada.It is A no brainer for them.Canada is the only country that to leave this happen and know what is going on WOW they did it to us again . Come on wake up Canada.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features